Live tape
Top 8, mentions 7d13,386TSLA3,041 mentions▲ +0.05SPCX2,592 mentions▲ +0.08GOOGL1,788 mentions▲ +0.03META1,437 mentions▲ +0.05CRWV1,266 mentions▲ +0.04NVDA1,179 mentions▲ +0.07QQQ1,135 mentions▲ +0.05NFLX948 mentions▲ +0.03

Equity · Healthcare

EXEL

NASDAQ

Exelixis (EXEL)

$59.90 +1.53% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 9, 2026
Price · Chart
56 sessions
$60.0 $50.0 23 Jul 9 Oct

The line runs $56 on 23 July through $59.90 on 9 October, on a scale from $50.0 to $60.0. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView TradingView chart · our licensed closes: 56 sessions, 23 Jul – 9 Oct 2026
Market cap $14.8B
P/E (TTM) 18.8
52-week range $34.54 – $59.90
Avg volume 99.2K

as of Oct 9, 2026

Exelixis (EXEL) insider trades

SEC Form 4 · last 90 days · newest reported trade 10 Aug 2026

In the 90 days to 22 Oct 2026, Exelixis insiders reported 1 open-market sale and no purchases (SEC Form 4); none has bought on the open market since 25 Nov 2025.

Open-market buys 0
Open-market sells 1
Net sold $527K
Non-trade filings 0
Date Insider Type Shares Value
10 Aug 2026 Beckerle Mary C Director Sell 9,812 $527K

Exelixis (EXEL) reported financials

SEC EDGAR XBRL SEC EDGAR

Exelixis reported revenue of $2.3B for the fiscal year ended 02 Jan 2026. Net income over the same period was $782.6M.

Figure Reported Period
Revenue $2.3B 02 Jan 2026 fiscal year
Net income $782.6M 02 Jan 2026 fiscal year
Diluted EPS $2.78 02 Jan 2026 fiscal year
Total assets $2.5B 03 Jul 2026 at period end
Total equity $1.8B 03 Jul 2026 at period end

Exelixis (EXEL) earnings

SEC EDGAR

Exelixis last reported earnings on 3 Jul 2026 for Q2 2026, with EPS of $0.82; no next date is announced in SEC filings yet.

Date Period EPS Revenue
03 Jul 2026 Q2 2026 $0.82 —
03 Apr 2026 Q1 2026 $0.79 —
02 Jan 2026 FY 2025 $2.78 —
03 Oct 2025 Q3 2025 $0.69 —
04 Jul 2025 Q2 2025 $0.65 —
04 Apr 2025 Q1 2025 $0.55 —
03 Jan 2025 FY 2024 $1.76 —
27 Sep 2024 Q3 2024 $0.40 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

Exelixis (EXEL) institutional holders (13F)

SEC Form 13F SEC EDGAR

11 of the 45 institutional funds we track reported a Exelixis position for the quarter ended 30 Jun 2026 — a combined $2.0B; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Renaissance Technologies Held (±25%) −2.2% shares 13,427,993 $730.6M
AQR Capital Management Held (±25%) −15.8% shares 11,023,943 $598.6M
D. E. Shaw & Co. Added +54.1% shares 5,551,747 $302.1M
Two Sigma Investments Added +90.8% shares 4,209,861 $229.1M
Millennium Management Added +30.4% shares 1,218,706 $66.3M
Marshall Wace Added +177.2% shares 831,506 $45.2M
Man Group Held (±25%) −10.6% shares 456,761 $24.9M
Bridgewater Associates Held (±25%) −16.7% shares 400,859 $21.8M
Fisher Asset Management Held (±25%) +18.6% shares 195,661 $10.6M
Citadel Advisors Trimmed −91.3% shares 70,924 $3.9M

Showing the 10 largest of 11 reported positions. The figures above count all of them.

Exelixis (EXEL) fails-to-deliver

SEC CNS data SEC

On 21 Sep 2026, 600 shares of Exelixis failed to deliver (about $35K).

Settlement date Shares failed Notional % of shares out
21 Sep 2026 600 $35K <0.001%

Exelixis (EXEL): frequently asked questions

From live data

Have Exelixis insiders bought or sold shares recently?

In the 90 days to 22 Oct 2026, Exelixis insiders reported 1 open-market sale and no purchases (SEC Form 4); none has bought on the open market since 25 Nov 2025.

How many institutions hold Exelixis?

11 of the 45 institutional funds we track reported a Exelixis position for the quarter ended 30 Jun 2026, per SEC Form 13F filings.

Has Exelixis had fails-to-deliver recently?

Yes. The most recent SEC fails-to-deliver record for Exelixis is dated 21 Sep 2026, when 600 shares failed to deliver.

When did Exelixis last report earnings?

Exelixis last reported earnings on 3 Jul 2026 for Q2 2026, with EPS of $0.82; no next date is announced in SEC filings yet.

What exchange is Exelixis listed on?

Exelixis trades on NASDAQ under the ticker EXEL.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), most closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 03 Jul 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARValuation computed from SEC EDGAR filings